Includes venture-backed biopharma companies that raised at least $50M in IPOs on US exchanges since January 2018
$ in millions
| Company name | Ticker | Series A date | Series A amount raised | Series A post-money | Series B date | Series B amount raised | Series B post-money | Series C date | Series C amount raised | Series C post-money | IPO date | IPO amount raised | IPO post-money | Therapeutic areas | Therapeutic modalities | Development stage at IPO |
|---|